2015
DOI: 10.1007/s00401-015-1526-9
|View full text |Cite
|
Sign up to set email alerts
|

Pathological α-synuclein distribution in subjects with coincident Alzheimer’s and Lewy body pathology

Abstract: We investigated the distribution patterns of Lewy body related pathology (LRP) and the effect of coincident Alzheimer disease (AD) pathology using a data-driven clustering approach that identified groups with different LRP pathology distributions without any diagnostic or researcher’s input in two cohorts including: Parkinson disease patients without (PD, n=141) and with AD (PD-AD, n=80), dementia with Lewy bodies subjects without AD (DLB, n=13) and demented subjects with AD and LRP pathology (Dem-AD-LB, n=308… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

9
118
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 138 publications
(127 citation statements)
references
References 47 publications
9
118
0
Order By: Relevance
“…2). Rather, differences in the interaction between α-syn and tau species or Aβ 1–42 may contribute to the variable progression and/or differential clinical and pathological features of PD [38]. In some autopsy studies of PD, topographical distribution of amyloid pathology and tau pathology were significantly correlated with rapid development of PD dementia [6, 19, 38].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…2). Rather, differences in the interaction between α-syn and tau species or Aβ 1–42 may contribute to the variable progression and/or differential clinical and pathological features of PD [38]. In some autopsy studies of PD, topographical distribution of amyloid pathology and tau pathology were significantly correlated with rapid development of PD dementia [6, 19, 38].…”
Section: Discussionmentioning
confidence: 99%
“…Rather, differences in the interaction between α-syn and tau species or Aβ 1–42 may contribute to the variable progression and/or differential clinical and pathological features of PD [38]. In some autopsy studies of PD, topographical distribution of amyloid pathology and tau pathology were significantly correlated with rapid development of PD dementia [6, 19, 38]. In fact, when we classified PD patients by quintile levels of CSF biomarkers, PD patients with low Aβ 1–42 and a high t-tau/Aβ 1–42 ratio, but not α-syn levels, showed more severe clinical symptoms compared with patients with high CSF Aβ 1–42 concentrations and low t-tau/Aβ 1–42 ratio values (Table 4).…”
Section: Discussionmentioning
confidence: 99%
“…Various neuropathological studies suggest that the spatial and temporal patterns of distribution of α-syn pathology in the CNS among the different types of synucleinopathies follow known patterns of synaptic connectivity [6, 14, 65]. This, in combination with recent studies showing that α-syn oligomers can be released by neurons and promote neurodegeneration and inflammation by propagating to other neurons [8, 12, 20, 37, 50] and glial cells [35], has strengthened the concept that cell-to-cell transmission of pathogenic forms of α-syn might play a role in the pathogenesis of synucleinopathies.…”
Section: Introductionmentioning
confidence: 99%
“…Converging evidence shows that PD patients with involvement of visual processing are at highest risk of PD dementia 2, 3. However, current measures of visuo‐perceptual function are poorly sensitive (eg, copying intersecting pentagons4 or clock drawing5 or require trained personnel and are time consuming to perform (such as the Vision Object and Space Perception battery6 or Benton's Judgment of Line Orientation7, 8.…”
mentioning
confidence: 99%